Navigation Links
NeoStem Completes $500,000 Private Placement With Strategic Investor
Date:12/3/2008

NEW YORK, Dec. 3 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Alternext US: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced that it has completed an above market financing for $500,000 with a strategic investor of units priced at $1.25 per unit with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at $1.75 per share.

The strategic investor consists of principals of Erye Pharmaceutical Co. Ltd ("Erye"), a more than 50-year old pharmaceutical company located in Suzhou, China. Erye currently manufactures over 100 drugs on seven Good Manufacturing Practices (GMP) lines, including small molecule drugs. Erye has begun its three year expansion and relocation program which is anticipated to enhance revenues, profits, and manufacturing capabilities in one of the fastest growing medical markets, the Peoples Republic of China. "We believe NeoStem and its management can guide us in identifying therapeutics and assist us in bringing them to the PRC market in an effort to enhance our drug pipeline," said Madame Zhang Jian, General Manager of Erye.

"We are extremely pleased by the vote of confidence this above market equity purchase demonstrates by our future partner in drug development in China," said Robin Smith, MD, MBA, Chairman and Chief Executive Officer of NeoStem.

"In November 2008, NeoStem agreed to acquire CHBP (OTC Bulletin Board: CHBP), which will give NeoStem a 51% controlling interest in Erye and should help to ultimately provide a stable balance sheet for growth. NeoStem will not only have an interest in traditional therapies in China through the Erye acquisition, but will be able to expand its therapeutic reach through a second acquisition in China, Shandong New Medicine Research Institute, which currently administers a multitude of treatments
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
2. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
3. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
4. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
5. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
6. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
7. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
8. NeoStem to Expand Stem Cell Collection Center Network to Florida
9. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
10. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
11. NeoStem to Present at Third Annual Stem Cell Summit in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  The University of California, San ... and UC San Diego Extension announced their third ... Aug.  12 – 14, 2015, at UC San ... provides an intense exposure to best practices and ... well-suited to biologists, process engineers and business executives ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - RepliCel ... clinical stage regenerative medicine company focused on the ... first participant in its Phase 1/2 clinical trial ... chronic unilateral Achilles tendinosis, has been enrolled and ... intra-tendon ultrasound-guided injections. RCT-01 is comprised of non-bulbar ...
(Date:6/30/2015)... ... June 30, 2015 , ... Southern ... accepted the position of vice president of instruction at Chippewa Valley Technical College ... greatly appreciated the opportunity to lead SIUE during the past three years,” Furst-Bowe ...
(Date:6/30/2015)... Florida (PRWEB) , ... June 30, 2015 , ... ... cannabis digital media company, launched “Cannavoices,” an unprecedented digital video and broadcast ... largest but also the most dynamic collection of legal medical cannabis stories ever ...
Breaking Biology Technology:UC San Diego Extension to Offer Third Annual Microbial Fermentation Workshop 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
... the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading,international pharmaceutical ... 31, 2007., 2007 Full Year Financial Highlights:, - ... in 2006 - Chemical Division,s ... $45.8 million in 2006. ...
... 31 NxStage Medical,Inc. (Nasdaq: NXTM ), ... that Tom Shea has joined the Company as ... 2008. Mr.,Shea will be responsible for all of ... Mr. Shea joins NxStage with more than ...
... MANASQUAN, NJ., March 31 BioSpace, the world,s leading,online ... will host,the Biotech Beach(TM) Career in La Jolla, CA ... at the Hyatt Regency La Jolla from 2 pm-7 ... science professionals from across Southern California will attend,the biotech ...
Cached Biology Technology:Dragon Pharma announces 2007 full year financial results 2Dragon Pharma announces 2007 full year financial results 3Dragon Pharma announces 2007 full year financial results 4Dragon Pharma announces 2007 full year financial results 5Dragon Pharma announces 2007 full year financial results 6Dragon Pharma announces 2007 full year financial results 7NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations 2NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations 3Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance 2
(Date:6/24/2015)... JOSE, Calif. , June 24, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... sensor to provide secure authentication for its latest ... recently reached more than 200 million shipments of ... with Sharp reinforces Synaptics, strength, scalability and leadership ...
(Date:6/23/2015)...   Valencell, a leader in performance ... recent study that illustrates its PerformTek biometric technology ... In a study conducted at Valencell,s Biometric Lab, ... Apple Watch against a chest strap – the ... The study demonstrated that Valencell,s biometric technology delivers ...
(Date:6/17/2015)... Germany , June 17, 2015 ... QIA) today launched new Investigator ® STR assay kits ... the United States . The new genetic fingerprint ... genomic markers (short tandem repeats or STRs) for DNA matching. ... the quality of DNA in each sample, a novel QIAGEN ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... (June 28 2013) A study carried out in India ... bone marrow stem cells in patients with type 2 ... when compared to a control group of TD2M patients ... , The study appears as an early e-publication for ...
... make a big difference. A "left-handed" molecule of a ... its mirror-image "right-handed" counterpart could be completely inactive. That,s ... crucial: Living organisms are made only from left-handed amino ... Now, a team of scientists at the U.S. ...
... the late spring, the 4000 elk of the Clarks ... following the greening grass into the highlands of the ... on vegetation fed by snowmelt. It,s a short trip ... uncommonly free of roads, fences, metropolitan areas, and other ...
Cached Biology News:Type 2 diabetes patients transplanted with own bone marrow stem cells reduces insulin use 2Tiny nanocubes help scientists tell left from right 2Tiny nanocubes help scientists tell left from right 3Declining fortunes of Yellowstone's migratory elk 2Declining fortunes of Yellowstone's migratory elk 3Declining fortunes of Yellowstone's migratory elk 4
Mouse monoclonal antibody raised against a partial recombinant ACTN4. NCBI Entrez Gene ID = ACTN4...
Rabbit polyclonal antibody to GluR2...
... Blocker Array II can be used to ... various proteins and sera that are commonly ... The array contains spots for 19 different ... Determination of antibody crossreactivity and species specificity, ...
... sufficient materials for 1,464 array sample elements. , ... , Blocker BSA in PBS (10X): 50 ... 10 g , BupH Phosphate Buffered ... 2 x 10 ml ampules , SuperSignal West ...
Biology Products: